Systemic mastocytosis, myelofibrosis and portal hypertension.
A case of systemic mastocytosis is described in which the finding on initial presentation was hepatosplenomegaly. No dermatological abnormality was present, and the bone marrow histology originally caused some confusion with primary myelofibrosis. The clinical course and the importance of distinguishing between these two diseases is discussed. The dermatological manifestation of systemic mastocytosis, in the form of urticaria pigmentosa, is well recognised, and alerts the physician to the underlying disease. In the absence of cutaneous signs, however, the diagnosis is less obvious. The case reported had predominantly marrow and splenic involvement by the disease process, giving rise to portal hypertension, and illustrates the problems of diagnosis which can arise.
This article has been cited by other articles:
-
Sucker, C., Mansmann, G., Steiner, S., Gattermann, N., Schmitt-Graeff, A., Loncar, R., Scharf, R. E., Stockschlader, M.
(2008). Fatal Bleeding Due to a Heparin-Like Anticoagulant in a 37-Year-Old Woman Suffering From Systemic Mastocytosis. CLIN APPL THROMB HEMOST
14: 360-364
[Abstract] -
Sumpio, B. E., O'Leary, G., Gusberg, R. J.
(1988). Variceal Bleeding, Hypersplenism, and Systemic Mastocytosis: Pathophysiology and Management. Arch Surg
123: 767-769
[Abstract]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
